Clinical Trials Browser

Completed × Has results × resiquimod × Clear all

NCT02126579 2024-02-28

MEL60

Phase 1/2 Completed

50 enrolled 13 charts

Melanoma, Neoplasms

NCT00960752 2021-08-13

Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist

Phase 2 Completed

47 enrolled 9 charts

Melanoma, Neoplasm Metastasis, Neoplasms